TrialJournal of comparative effectiveness research2025

Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.

Dmitry Vlodavets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.